Immunic (IMUX) Earnings Date & Reports

A.I. Advisor
published Earnings

IMUX is expected to report earnings to fall 22.00% to -23 cents per share on August 01

Immunic IMUX Stock Earnings Reports
Q2'24
Est.
$-0.23
Q1'24
Missed
by $0.04
Q4'23
Beat
by $0.03
Q3'23
Beat
by $0.04
Q2'23
Missed
by $0.01
The last earnings report on May 08 showed earnings per share of -30 cents, missing the estimate of -25 cents. With 112.86K shares outstanding, the current market capitalization sits at 127.01M.
View a ticker or compare two or three
IMUX
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals and oral therapies for the treatment of chronic inflammatory and autoimmune diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1200 Avenue of the Americas
Phone
+1 332 255-9818
Employees
77
Web
https://www.imux.com